SERA PROGNOSTICS, INC. Cash and Restricted Cash
SERA PROGNOSTICS, INC. (SERA) had Cash and Restricted Cash of $4.40 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.40M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.17M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.94M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.08M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $4.40M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $4.17M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $3.94M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $4.08M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.02M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $5.23M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $4.04M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $2.68M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $4.66M 10-Q · filed 2025-08-06 |
| 2024-03-31 | $4.24M 10-Q · filed 2025-05-07 |
| 2023-12-31 | $3.88M 10-K · filed 2026-03-18 |
| 2023-09-30 | $9.65M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $32.28M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $27.20M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $29.88M 10-K · filed 2025-03-19 |
| 2022-09-30 | $38.81M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $53.89M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $64.08M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $58.93M 10-K · filed 2024-03-20 |
| 2021-09-30 | $82.48M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $90.85M 10-Q · filed 2022-08-10 |
| 2021-03-31 | $60.02M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $13.53M 10-K · filed 2023-03-22 |
| 2020-09-30 | $18.68M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $23.63M 10-Q · filed 2021-08-30 |
| 2019-12-31 | $21.39M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |